Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Fibrinogenase Injection

Approval Number

国药准字H11022157

Company北京赛升药业股份有限公司

Registration Date

October 16, 2020

Previous Approval Numbers

国药准字H11022157

Drug Information

Generic Name

纤溶酶注射液

Brand Name

赛盈

Dosage Form

注射剂(小容量注射剂)

Strength

1ml:100单位

Drug Type

化学药品

Registration Date

October 16, 2020

Company Information

Applicant Company

Company Name北京赛升药业股份有限公司

Company Address

北京市北京经济技术开发区兴盛街8号

Manufacturing Company

Company Name北京赛升药业股份有限公司

Company Address

北京市北京经济技术开发区兴盛街8号；北京市北京经济技术开发区凉水河二街乙2号院

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy